Accessibility: Skip TopNav
Sam Backenroth, Chief Financial Officer, VBL Therapeutics
Sam Backenroth, Chief Financial Officer, VBL Therapeutics
Format
JPEG
Source
Vascular Biogenics Ltd.
Téléchargements
Original
Grand
Moyen
Petit